Similar articles

• Pathways of purine ribonucleotide catabolism in Ehrlich ascites tumor cells in vitro.

  Crabtree GW, Henderson JF. Crabtree GW, et al. Can J Biochem. 1971 Aug;49(8):959-63. doi: 10.1139/o71-139. Can J Biochem. 1971. PMID: 5165993 No abstract available.
• Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro.

  Crabtree GW, Henderson JF. Crabtree GW, et al. Cancer Res. 1971 Jul;31(7):985-91. Cancer Res. 1971. PMID: 5560389 No abstract available.
• Resistance to purine ribonucleoside analogues in an ascites tumor.

  Caldwell IC, Henderson JF, Patterson AR. Caldwell IC, et al. Can J Biochem. 1967 May;45(5):735-44. doi: 10.1139/o67-084. Can J Biochem. 1967. PMID: 6035139 No abstract available.
• Inhibition of purine biosynthesis de novo and of Ehrlich ascites tumor cell growth by 6-methylmercaptopurine ribonucleoside.

  Shantz GD, Fontenelle LJ, Henderson JF. Shantz GD, et al. Biochem Pharmacol. 1972 Apr 15;21(8):1203-6. doi: 10.1016/0006-2952(72)90115-3. Biochem Pharmacol. 1972. PMID: 5034201 No abstract available.
• Inhibitors of purine metabolism in Ehrlich ascites tumor cells in vitro.

  Lau KF, Henderson JF. Lau KF, et al. Cancer Chemother Rep 2. 1972 Nov;3(1):95-109. Cancer Chemother Rep 2. 1972. PMID: 4499907 No abstract available.